Float Short %

0.48

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.1

EPS Last/This Y

-0.25

EPS This/Next Y

0.43

Price

0.58

Target Price

Analyst Recom

Performance Q

-74.99

Relative Volume

0.69

Beta

-0.31

Ticker: PRPH

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2024-12-19	PRPH	0.655	0.07	0.00	1249
2024-12-20	PRPH	0.641	0.07	0.00	1279
2024-12-23	PRPH	0.6323	0.07	0.00	1279
2024-12-24	PRPH	0.64	0.07	0.00	1279
2024-12-26	PRPH	0.6384	0.06	0.00	1395
2024-12-27	PRPH	0.6273	0.06	0.00	1395
2024-12-30	PRPH	0.69	0.06	0.06	1392
2024-12-31	PRPH	0.75	0.06	0.02	1499
2025-01-02	PRPH	0.849	0.06	0.00	1548
2025-01-03	PRPH	0.8035	0.06	0.00	1557
2025-01-06	PRPH	0.73	0.05	0.00	1703
2025-01-07	PRPH	0.7175	0.05	0.00	1707
2025-01-08	PRPH	0.58	0.05	0.00	1753
2025-01-09	PRPH	0.589	0.05	0.00	1753
2025-01-10	PRPH	0.645	0.05	0.00	1760
2025-01-13	PRPH	0.6475	0.05	0.00	1760
2025-01-14	PRPH	0.6039	0.05	0.00	1766
2025-01-15	PRPH	0.6199	0.05	0.00	1766
2025-01-16	PRPH	0.6	0.05	0.00	1767
2025-01-17	PRPH	0.581	0.05	0.00	1767
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2024-12-19	PRPH	0.66	52.9	-	-1.23
2024-12-20	PRPH	0.63	52.9	-	-1.23
2024-12-23	PRPH	0.63	52.9	-	-1.23
2024-12-24	PRPH	0.63	52.9	-	-1.23
2024-12-26	PRPH	0.63	52.9	-	-1.23
2024-12-27	PRPH	0.64	52.9	-	-1.23
2024-12-30	PRPH	0.71	52.9	-	-1.23
2024-12-31	PRPH	0.75	52.9	-	-1.23
2025-01-02	PRPH	0.88	52.9	-	-1.23
2025-01-03	PRPH	0.83	52.9	-	-1.23
2025-01-06	PRPH	0.73	52.9	-	-1.23
2025-01-07	PRPH	0.72	52.9	-	-1.23
2025-01-08	PRPH	0.59	52.9	-	-1.23
2025-01-09	PRPH	0.59	52.9	-	-1.23
2025-01-10	PRPH	0.65	52.9	-	-1.23
2025-01-13	PRPH	0.65	52.9	-	-1.23
2025-01-14	PRPH	0.60	52.9	-	-1.23
2025-01-15	PRPH	0.60	52.9	-	-1.23
2025-01-16	PRPH	0.60	52.9	-	-1.23
2025-01-17	PRPH	0.58	52.9	-	-1.23
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2024-12-19	PRPH	0.00	2.67	0.71
2024-12-20	PRPH	0.00	2.67	0.71
2024-12-23	PRPH	0.00	2.67	0.71
2024-12-24	PRPH	0.00	2.67	0.71
2024-12-26	PRPH	0.00	2.67	0.53
2024-12-27	PRPH	0.00	2.67	0.53
2024-12-30	PRPH	0.00	2.67	0.53
2024-12-31	PRPH	0.00	2.67	0.53
2025-01-02	PRPH	0.00	2.67	0.53
2025-01-03	PRPH	0.00	2.67	0.53
2025-01-06	PRPH	0.00	2.67	0.53
2025-01-07	PRPH	0.00	2.67	0.53
2025-01-08	PRPH	0.00	2.67	0.53
2025-01-09	PRPH	0.00	2.67	0.53
2025-01-10	PRPH	0.00	2.67	0.53
2025-01-13	PRPH	0.00	2.67	0.48
2025-01-14	PRPH	0.00	2.67	0.48
2025-01-15	PRPH	0.00	2.67	0.48
2025-01-16	PRPH	0.00	2.67	0.48
2025-01-17	PRPH	0.00	2.67	0.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.35

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

Institutional Transactions

2.67

Beta

-0.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.4

Max Drawdown 5-Year %

-96.3

Target Price

P/E

Forward P/E

PEG

P/S

1.11

P/B

0.3

P/Free Cash Flow

EPS

-1.5

Average EPS Est. Cur. Y

-1.23

EPS Next Y. (Est.)

-0.8

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-217.64

Relative Volume

0.69

Return on Equity vs Sector %

-91.9

Return on Equity vs Industry %

-83.1

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.31

EBIT Estimation

ProPhase Labs, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 113

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today

news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance

stock history PRPH – ProPhase Labs Inc invest stock market

stock prices PRPH premarket after hours

ticker PRPH fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PRPH

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y